NMTC
Nasdaq’s ultimatum, meet the reverse split
NeuroOne Medical Technologies is reaching for the corporate equivalent of a last-minute tie straightener: a reverse stock split. The goal is simple — regain Nasdaq compliance and avoid getting kicked further down the exchange’s list of worries.
Why investors should care
A reverse split doesn’t magically fix the business, but it does change the share count and the price per share. That matters because it can help a company clear minimum bid-price rules, keep its listing intact, and avoid the drama that comes with noncompliance.
The not-so-fun part
If you’re holding the stock, the move is a reminder that the market has been pricing in a lot of skepticism. Reverse splits can sometimes buy time and breathing room, but they’re usually not the kind of headline companies put on the fridge.
Big picture:
This is less about growth and more about survival mode. NeuroOne is trying to keep its Nasdaq seat before the music stops, and investors will be watching whether this is a reset — or just a cosmetic fix.